Tier 3 — preclinical

Displacement of bilirubin from albumin by berberine

Chan E
Biology of the neonate 1993 63(4):201-208

Bibliography

PubMed
PMID 8513024
Funding
Funding was not established from the accessible source; this is not a declaration of no funding.
Competing interests
A complete competing-interest declaration was not available in the accessible source; no absence of conflicts is inferred.

Study snapshot

DesignAnimal and/or cellular experimental study
ModelIn-vitro bilirubin-protein binding and adult rats
SampleBilirubin-binding assays and adult rat groups
InterventionBerberine in vitro and intraperitoneally at 10 or 20 mg/kg/day in rats
Duration7-day rat exposure
EndpointsBilirubin-protein binding; Unbound and total bilirubin in rats

What the study showed, in plain terms

Laboratory and rat experiments found reduced bilirubin protein binding. This is mechanistic safety context for vulnerable neonates, not a measured human pregnancy-risk estimate.

Key findings

  • Laboratory and rat experiments found reduced bilirubin protein binding. This is mechanistic safety context for vulnerable neonates, not a measured human pregnancy-risk estimate.

What this study can and cannot tell us

Nonhuman exposure and injection route; no human safe dose or pregnancy safety threshold was established.

Source detail: indexed abstract and bibliographic record; unavailable methods or disclosures are identified rather than assumed.

Citation network

Articles citing this research paper

6 articles

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified